BioSpace News Archive

Angelini Pharma, part of the privately owned Angelini Industries, and JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) announced today that they entered into an exclusive global development and commercialization agreement for the development of novel biologic therapies that applies J-Brain Cargo®, blood-brain barrier penetrating technology, for the treatment of epilepsy.

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies (CGTs), has today announced a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf that brings together process development expertise, tools and technologies for scalable CGT manufacturing.

Nanoscope Therapeutics Inc. today announced that its Multi-Characteristic Opsin (MCO) gene therapy platform will be featured in a presentation at the 26th ASGCT Annual Meeting, taking place May 16-20, 2023 in Los Angeles, CA.

IMUNON, Inc. today announced financial results for the three months ended March 31, 2023, and provided an update on its clinical development programs with IMNN-001.

Madrigal Pharmaceuticals, Inc. announced today its management team will participate in a fireside chat at the The JMP Securities Life Sciences Conference on Tuesday, May 16, 2023 at 10:30 am ET.

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results and provided business updates for the first quarter ended March 31, 2023.

Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.

Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that it will deliver an oral presentation at the European Congress of Endocrinology (ECE) 2023 Annual Meeting, which is being held May 13-16 in Istanbul, Turkey.

Bioventus Inc., a global leader in innovations for active healing, announced the Company plans to file Form 12b-25, Notification of Late Filing, for its Quarterly Report on Form 10-Q for the period ended April 1, 2023, on May 11, 2023.

GreenLight Biosciences, PBC, a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, reported operational highlights and financial results for the first quarter ended March 31, 2023.